Oncocyte Announces Bio-Rad Partnership and Raises $15.8M to Accelerate Transplant Diagnostic Launch
Oncocyte's Strategic Collaboration and Financial Discipline Highlight First Quarter Achievements Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, reported key ...